Automated Microbiology Market
Report ID: SQMIG35A3185
Report ID: SQMIG35A3185
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3185 |
Region:
Global |
Published Date: January, 2026
Pages:
189
|Tables:
89
|Figures:
68
Global Automated Microbiology Market size was valued at USD 9.0 billion in 2024 and is poised to grow from USD 9.99 billion in 2025 to USD 23.02 billion by 2033, growing at a CAGR of 11.0% during the forecast period (2026-2033).
One of the major factors fueling the global automated microbiology market growth is the increasing incidence of infectious diseases worldwide. The chances for rapid and reliable microbiological identification and susceptibility testing have increased due to HAIs, antibiotic-resistant organisms, and foodborne pathogens. Automated microbiology systems offer shortened turnaround times and provide higher diagnostic accuracy through mass spectrometry, PCR-based detection, and AI-based microbial identification.
Modernization of automated microbiology is characterized by a seamless integration of automation with laboratory activities to enhance productivity and optimize turnaround time. Laboratory operations are undergoing a revolution where cloud-based data management and connectivity permit real-time monitoring and sharing. This revolution, besides increasing attention to quality control and regulatory compliance, also serves to drive development in software and instrumentation. Moreover, supplier-healthcare provider partnerships lead to the development of innovative solutions tailored for the specific needs of diagnostic laboratories.
What Role Does AI Play in Reducing Turnaround Time in Microbiology Labs?
AI is in fact influencing tremendous changes to the global automated microbiology market outlook, easing diagnosis in both clinical and research settings. This includes automation of antimicrobial susceptibility testing, pathogen identification, and colony counting through AI-driven image analysis and machine learning. The automation hence would speed up the turnaround and greatly alleviate manual labor. One should take note that AI-based colony readers have been extensively deployed in the laboratories. Achieving over 90% in detection accuracy, these technologies allow for high-throughput workflows that accelerate clinical decisions and quality assurance. AI systems are also assisting in evaluating phenotypic and genomic data such that standard diagnostic procedures can be established by laboratories to more rapidly identify strains.
Market snapshot - 2026-2033
Global Market Size
USD 8.43 Billion
Largest Segment
Reagents & Kits
Fastest Growth
Instruments
Growth Rate
10.69% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Automated Microbiology Market is segmented by Sample Type, Product Type, Automation Level, Application, End User and region. Based on Sample Type, the market is segmented into Blood, Urine, Tissue, Food and Water. Based on Product Type, the market is segmented into Automated Incubators, Automated Colony Counters, Automated Microbiology Analyzers and Automated Media Preparation Systems. Based on Automation Level, the market is segmented into Semi-Automated and Fully Automated. Based on Application, the market is segmented into Clinical, Food and Beverage, Pharmaceutical and Environmental. Based on End User, the market is segmented into Hospitals and Clinics, Reference Laboratories, Research Institutions, Food and Beverage Companies and Pharmaceutical Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
What Makes Reagents & Kits the Backbone of Automated Microbiology Systems?
As per the 2025 automated microbiology market analysis, the reagents & kits category dominated the market with almost half (47.86%) of the relevant sales within the sector. Many factors, such as the increasing need for rapid, accurate microbiological identification, an ever-growing incidence of infectious disorders, and increased automation in clinical diagnostics-all spur in this industry. Innovative formulations of reagents such as molecular diagnostic kits and ready-to-use culture media hasten turnaround times and simplify laboratory procedures. There is a growing demand for premium reagents in this industry as stringent regulatory frameworks guide microbiological testing in the food industry, pharmaceuticals, and healthcare. Apart from, they are indulged in boosting fortunes in innovation in multiplex PCR kit development and application of artificial intelligence in assay development to enhance the accuracy of diagnostics and streamline processes thereby driving the growth in the market.
However, the instruments segment is anticipated to have the highest automated microbiology market share. The increasing demand for high-throughput microbiological testing with emerging automation technology and incidences of infectious disease are the main factors driving this change. Automated tools such as blood culture analyzers, microbial identification systems, and antibiotic susceptibility testing devices are increasingly being used in laboratories. They are aimed at increasing accuracy, reducing human error, and speeding processes. The market is also expanding because of the growing demand and developments in AI and machine learning for fully integrated diagnostic systems.
What Role Does Rapid Turnaround Time Play in Clinical Diagnostics Leadership?
As per the 2025 automated microbiology market forecast, the clinical diagnostics segment registered the highest revenue share, constituting more than 50.83% of the overall share. The growing prevalence of infectious diseases, antibiotic resistance, and developing need for fast and accurate diagnostic procedures to facilitate the flourishing of this segment. Automation is improving laboratory efficiencies by reducing manual work and eliminating human errors while increasing the turnaround time for antibiotic susceptibility testing and microbiological identification. Technological advances, such as integrated automation platforms, molecular diagnostics, and AI data analysis, are further accelerating the adoption in clinical laboratories.
However, the biopharmaceutical production category is expected to be the fastest-growing category, with advanced technology as the key driver for that growth. High-throughput microbial detection, AI-powered analytics, and real-time monitoring systems are increasing efficiency in the workflows. Besides, they minimize the need for human intervention, hence minimizing the chances for mistakes. Moreover, an increasing need for reliable microbiological testing solutions has emerged as biologics, vaccines, and cell and gene therapies get into higher production. The need for such systems for ensuring efficacy and safety puts a further demand for automated microbiological systems from the biopharmaceutical industry.
To get detailed segments analysis, Request a Free Sample Report
Why Does North America Lead the Global Automated Microbiology Market?
As per the automated microbiology market regional forecast, North America dominated the market with a dominant share of more than 41.29% in 2025. This is due to advanced healthcare infrastructure for people, wide-ranging rapidly increasing infectious diseases, and an increasing focus on concerns of antibiotic resistance. The region possesses stringent requirements for microbiological testing in clinical diagnostics, pharmaceutical manufacture, and food safety under the FDA, CDC, and other regulatory bodies. Hence, the rising demand for automated solutions.
Automated Microbiology Market in the US
The automated microbiology sector in the U.S. is driven by an advanced healthcare infrastructure, an increasing prevalence of infectious diseases, and rising concern regarding antibiotic resistance. The introduction of strict guidelines in these areas by the FDA further spurs use of automated solutions. The increase in robotics, AI, and machine learning in microbiology laboratories promotes enhanced accuracy and productivity while reducing turnaround times. In addition, large investments in research and development by major industry giants such as BD, Thermo Fisher Scientific, and bioMérieux will propel the market growth.
Automated Microbiology Market in Canada
The automated microbiology industry in Canada has well-established roots and is steadily expanding. This development is largely due to a strong public healthcare system, rigorous diagnostic processes, and a history of lab automation adoption. Automated antimicrobial susceptibility testing and identification, as well as automated culture technologies, have become increasingly available in hospitals and referral laboratories. This transition can best address personnel shortages and the rising number of infectious disease tests. Furthermore, policy initiatives of the government toward digitization of the healthcare sector and monitoring antibiotic resistance put national demand into modern microbiology solutions.
What Impact Do Government Investments in Diagnostics Have on Market Expansion in Asia-Pacific?
The automated microbiology market in Asia Pacific is hugely growing due to the increasing above-discussed factors, such as augmenting pharmaceutical and biotech sectors, growing infectious diseases incidences, and increasing healthcare expenditure in the region. To enhance laboratory productivity and better patient outcomes, countries in the region have made investments in the latest diagnostic technologies. Rising demand for such technologies has further been propelled by increasing governance and AI-assisted automation and awareness regarding antibiotic resistance. Likewise, initiatives in regulatory changes as well as international collaborations in microbiological research further drive advances and growth in the areas of clinical, pharmaceutical, and food safety.
Automated Microbiology Market in China
The rapidly growing healthcare sector and the increasing government spending on diagnostics and intensive microbiological quality control in food safety and pharmaceuticals keep the automated microbiology market of the country percolating. Hospitals and diagnostic laboratories are moving toward automation for faster and more accurate microbiological identification because of the increasing burden of hospital-acquired infections and antibiotic resistance. The growing availability of AI-powered diagnostics, automation, and local manufacture of microbiological instruments makes the automated solutions more accessible, driving market growth.
Automated Microbiology Market in Japan
The advanced healthcare system, pervasive use of robotics and AI-based automation, and booming biotechnology and pharmaceuticals at the place deliver success to Japan in the automated microbiology industry. Very keen needs for accurate automated microbiology equipment arise mostly from the strict laws governing microbial testing in this country for both clinical and industrial applications. Further, due to the aging population and increased emphasis on infection control, the rapid diagnostic solutions are becoming more attractive in hospitals and research institutions in Japan.
How Are Strategic Collaborations Among Industry Players Boosting European Market Development?
In Europe, several factors, such as stringent regulatory framework, technology advancement, and widespread concern for antibiotic resistance, propel the automated microbiology market penetration. Economic requisites for automated diagnostic solutions are growing in the pharmaceutical, food safety, and healthcare industries due to the extremely rigid microbiological testing standards imposed by the European Medicines Agency and its regulatory colleagues. In addition, the need for more laboratory automation and AI-enabled diagnostics is driving efficiency, while various strategic collaborative approaches applied by major players are creating further impetus for the entire market in the region.
Automated Microbiology Market in UK
The UK automated microbiology market is being driven by factors such as government initiatives for enhancing diagnostic capabilities, increasing concerns over antibiotic resistance, and higher investments in healthcare automation. These have been mainly advanced by the National Health Service (NHS) of the country to increase productivity and reduce diagnostic turnaround time by employing AI and automated solutions for microbiology. Moreover, straining laws applied against food safety and pharmaceutical microbiological testing propel companies to integrate state-of-the-art automated systems.
Automated Microbiology Market in Germany
Germany has a strong healthcare system, an advanced biopharmaceutical sector, and stringent microbiological testing regulations, all contributing to the expansion of the automated microbiology market. The country serves as an epicenter of microbiology research and innovation by actively investing in AI-driven automation and high-throughput diagnostic capabilities. The other factor contributing to the expansion of this market is an increasing application of automated microbiology systems in hospitals, diagnostic laboratories, and the pharmaceutical sector, being supported from government research and healthcare initiatives.
Automated Microbiology Market in France
With a strong clinical diagnostics infrastructure and many foreign diagnostics companies, France ranks as a significant European market for automated microbiology. Renovation projects in hospitals, stringent regulations, and a national commitment toward combating antibiotic resistance all endorse the adoption. French laboratories are increasingly using automation and AI-powered platforms to speed turnaround times, standardize workflows, and manage large numbers of samples efficiently, both in public and private healthcare settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Automated Microbiology Market Drivers
Increasing Infectious Disease Burden
Testing Standards and Regulatory Support
Automated Microbiology Market Restraints
Exorbitant Capital and Ongoing Expenses
Integration Challenges and Skilled Workforce Shortfalls
Request Free Customization of this report to help us to meet your business objectives.
Some minimal consolidation exists in the automated microbiology market, with established diagnostic and life sciences companies at the forefront of providing a suite of platforms and products to their customers. Accuracy, speed of operation, AI integration, and networking capabilities are the basis for competitive advantage. While smaller, specialized companies will focus on niche solutions, larger ones will focus on international expansion and R&D projects with strategic partnerships. Therefore, the third factor impacting market evolution and innovation in diagnostic automation is collaboration among research institutions, clinical laboratories, and automation technology developers.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the automated microbiology market is racing ahead, fueled by ever-increasing incidences of infectious diseases, stringent regulatory requirements, and a need for faster and more accurate diagnostic tools. AI, full automation, and large-scale international investments to modernize labs are some of the contributing factors for this growth. Major players such as BD, Thermo Fisher, and bioMérieux, while relatively newer entrants are presenting disruptive ideas around automation, artificial intelligence, and high-throughput methodologies. The market does seem to have good prospects, notwithstanding the initial capital investment and trained personnel required, especially in food safety, pharmaceutical testing, and clinical diagnostics. The market is expected to continue growing at a more steady pace during the projection years due to the advancement of technologies and continued support from governments.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 9.0 billion |
| Market size value in 2033 | USD 23.02 billion |
| Growth Rate | 11.0% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Automated Microbiology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Automated Microbiology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Automated Microbiology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Automated Microbiology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Automated Microbiology Market size was valued at USD 8.43 Billion in 2025 and is poised to grow from USD 9.34 Billion in 2026 to USD 19.01 Billion by 2033, growing at a CAGR of 10.69% during the forecast period (2026-2033).
Some minimal consolidation exists in the automated microbiology market, with established diagnostic and life sciences companies at the forefront of providing a suite of platforms and products to their customers. Accuracy, speed of operation, AI integration, and networking capabilities are the basis for competitive advantage. While smaller, specialized companies will focus on niche solutions, larger ones will focus on international expansion and R&D projects with strategic partnerships. Therefore, the third factor impacting market evolution and innovation in diagnostic automation is collaboration among research institutions, clinical laboratories, and automation technology developers. 'BD (Becton Dickinson)', 'Thermo Fisher Scientific', 'bioMérieux', 'Siemens Healthineers', 'Sysmex Corporation', 'Agilent Technologies', 'QIAGEN', 'PerkinElmer', 'Danaher Corporation', 'Hoffmann-La Roche', 'Copan Diagnostics', 'Accelerate Diagnostics'
With the increasing prevalence of bacterial, viral, and fungal diseases, there is much greater impetus for the automation of microbiology. Urgently needed are fast and accurate pathogen identification systems for nosocomial infections, foodborne outbreaks, and the rising incidence of infectious diseases around the world. The importance of automated systems in clinical diagnostics, pharmaceutical testing, and food safety is that they are necessary for the reduction of turnaround times, improve diagnostic accuracy, and support timely clinical decisions.
AI and Intelligent Automation Integration: Automated microbiology is now one of the few microbiology processes being continued by artificial intelligence. Underpinning AI and machine learning, automation gives an improvement to predictive diagnosis, image analysis, and colony recognition facts. The knowledge-reliant data, multiple synthesis of these three, significantly improves accuracy; thereby human variances in error are reduced. Together with tested intelligent lab ecosystems that provide linkage, this technology ensures skin-and-bone telepathy is utilized in the diagnostic decision-making process, a state-of-art cloud analytics remote-monitoring solution which soon going to revolutionize how operational laboratories work.
Why Does North America Lead the Global Automated Microbiology Market?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
